BPC‑157 is a naturally occurring peptide that appears to act like a stem‑cell signal, prompting the body to rebuild damaged tissue. Dr. Jason Schuster highlights its potential to address leaky gut, liver and brain injury, neuropathies, and to support faster healing than conventional steroid injections.
A natural protein fragment
In the video Dr. Schuster describes BPC‑157 as a peptide derived from a gastric protein that has been studied in animal models for brain injury and leaky‑gut syndrome. He notes that human research is limited because pharmaceutical companies avoid non‑patentable substances.
Driving homeostatic healing
According to Dr. Schuster, BPC‑157 reduces sympathetic hyper‑activity and enhances parasympathetic tone, promoting autonomic nervous system balance. This shift triggers a positive feedback loop that restores mitochondrial energy, vascular growth, and nerve regeneration, contrasting the negative feedback loops seen in chronic inflammation.
- Reduces sympathetic over‑drive
- Increases parasympathetic activity
- Supports mitochondrial energy production
- Stimulates angiogenesis and nerve regrowth
Broad tissue‑repair effects
Dr. Schuster lists several conditions where BPC‑157 has shown benefit in animal studies and early human observations: counteracting leaky‑gut syndrome, aiding liver and brain recovery, improving oxygenation after concussion, treating diabetic neuropathy, insulin resistance, and accelerating tendon, ligament, muscle, cartilage, and vascular healing. He compares its outcomes to steroid injections, stating that steroids merely reduce inflammation whereas BPC‑157 both reduces inflammation and speeds healing.
- Leaky‑gut and intestinal barrier repair
- Liver and brain tissue protection
- Enhanced recovery from concussions
- Diabetic neuropathy and insulin resistance improvement
- Faster tendon, ligament, muscle and cartilage regeneration
Typical regimens and side‑effects
The video references studies that used 2 mg of BPC‑157 paired with 3 mg of thymosin‑beta‑4, and others that used 4 mg BPC‑157 with 6 mg thymosin‑beta‑4. Dr. Schuster reports that serious adverse events are rare; the most common minor side‑effects are nausea, stomach upset, and headaches. He stresses obtaining the peptide from reputable 503A compounding pharmacies or qualified functional‑medicine physicians.
- Study dose range: 2 – 4 mg BPC‑157 per injection
- Often combined with thymosin‑beta‑4 (3 – 6 mg)
- Minor side‑effects: nausea, gastrointestinal discomfort, headaches
- Source from 503A compounding pharmacy for highest purity
“Steroid injections reduce inflammation but slow healing; BPC‑157 reduces inflammation and speeds up healing.”— Dr. Jason Schuster
Dr. Schuster's short takes on this topic — tap to play.
Go deeper than the summary
Dr. Schuster's accredited courses on supplementation, epigenetics, and peptide therapy — the full research, dosing, and video breakdowns.